CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (52)	8/27/2001 7:13:08 PM
From: Miljenko Zuanic	Read Replies (1) of 126

No respect for small Corvas when street is talking about small molecules and protease inhibitors. They priced news with ~$9MM in MC, while for similar (in distance) events CVTX got ~$100M in MC. Maybe investors still have bitter taste from CVAS HCV and fXa/thrombin programs and collaboration with Schering. However, none yet have break-true compounds for this two target, so why to blame CVAS for failure. Nonetheless, I think that Schering direct thrombin inhibitor (from CVAS) is still alive. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next